Part of the Technology Updates series, this fact sheet describes PATH's work to develop rapid tests for cervical cancer.

Publication date: July 2013

Region: Global

Part of series: Technology Updates

This guide introduces the retinol binding protein enzyme immunoassay (RBP-EIA) to potential advocates and users, and provides information about its prospective role in public health.

Author: Hix J; Levin C; Gorstein J

Publication date: 2003

Region: Global

This document serves as a guide to phlebotomists and a training aid in the proper methods of obtaining blood samples for analysis by the retinol-binding protein enzyme immunoassay (RBP-EIA) used in testing for vitamin A deficiency.

Publication date: 2005

Region: Global

This document summarizes available evidence for the validation and establishment of a rapid, field-based tool for the assessment of vitamin A deficiency using the retinol-binding protein immunoassay (RBP-EIA) test.

Publication date: 2006

Region: Global

This Alliance for Cervical Cancer Prevention fact sheet summarizes evidence published since 2009 on cervical cancer screening approaches for low-resource settings.

Publication date: May 2011

Region: Global

The fourth annual policy report from the Global Health Technologies Coalition outlines actions the United States can take to help reduce deaths, extend lives, and secure healthier futures by supporting research for new health tools.

Publication date: February 2013

Region: North America and Europe

Part of series: GHTC's annual policy reports

Part of the Technology Updates series, this fact sheet describes PATH's work to develop a rapid, low-cost test to detect vitamin A deficiency.

Publication date: April 2012

Region: Global

Part of series: Technology Updates

Part of the Technology Updates series, this fact sheet describes PATH's work to develop a simple, affordable test for multidrug-resistant tuberculosis.

Publication date: July 2013

Region: Global

Part of series: Technology Updates

Demonstration of the PATH enteric flow-through assay as a rapid and cost effective method for detecting pathogenic bacteria in stool samples in low-resource settings. Presented at the American Association for Clinical Chemistry Oak Ridge Annual Conference, April 17, 2006; San Jose, CA.

Author: Dillman L, Fichtenholtz A, Weigl B

Publication date: April 2006

Region: Global

The pro-viral DNA capture card maintains the fundamental value provided by dried blood spots (ease of collection and transport from remote settings) while reducing the costs and time of performing pediatric HIV testing in the laboratory. Presented at: AACC 42nd Annual Oak Ridge Conference, April 22, 2010; San Jose, CA.

Author: Stevens DS, Barfield CA, Emery S, Overbaugh J, Gerlach J

Publication date: April 2010

Region: Global

An overview of a method of sample preparation by smart polymers for detection in an immunoassay, demonstrated as part of a diagnostics test for Chlamydia trachomatis. Presented at: 38th Annual American Association of Clinical Chemistry (AACC) Oakridge Conference, April 21, 2006; San Jose, CA.

Author: Kulkarni S, Peck R, Barfield C, et al

Publication date: April 2006

Region: Global

This fact sheet describes how the START-UP project is working with private-sector partners to develop two new tests that detect infection with the types of human papillomavirus (HPV) that cause cervical cancer. Designed for use in low-resource settings, these screening tools are an innovative answer to the challenge of early detection of the precursors of cervical cancer.

Publication date: July 2009

Region: Global

In low-resource settings, diabetes and tuberculosis are common among the same populations, and they amplify each other. PATH's principles and experiences guide our work in fighting these intersecting epidemics through innovation and collaboration.

Publication date: November 2012

Region: Global

This website about PATH’s Technology Solutions global program provides an overview of the program and its featured projects. See other PATH program websites.

Publication date: 2013

Region: Global

Part of series: PATH's program websites

This fact sheet provides an overview of PATH's work to adapt, design, develop, and advance health technologies to improve global health.

Publication date: December 2011

Region: Global

Part of series: PATH's areas of focus fact sheets

Demonstration of the use of a magnetic immunochromatographic strip (ICS) assay with a reader to detect recombinant HPV-16 E6. The magnetic ICS assay was able to detect as little as 2.6ng of protein. Presented at: 38th Annual Oak Ridge Conference, April 20, 2006; San Jose, CA.

Author: Peck R, Schweizer J, Weigl B, et al

Publication date: April 2006

Region: Global

This fact sheet from the Global Health Technologies Coalition examines how US leadership in global health research helps to saves lives worldwide and provides domestic economic benefits.

Publication date: March 2011

Region: North America and Europe

This document assesses the correspondence between retinol and retinol-binding protein (RBP), as well as the stability of RBP subjected to varying temperature conditions over time, the effect of light, and the feasibility of using dried blood spots. The assessment is part of a larger project examining the use of the RBP enzyme immunoassay (RBP-EIA) to test for vitamin A deficiency.

Publication date: 2006

Region: Africa

This document shares data from Guinea-Bissau that provide validation of the retinol-binding protein enzyme immunoassay (RBP-EIA) test from serum samples, while also providing initial data on the feasibility of using dried blood samples as a specimen type for the assessment of vitamin A deficiency in the field.

Publication date: 2006

Region: Africa